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ABSTRACT
RNA Polymerase II (Pol II), the enzyme that transcribes all messenger
RNAs (mRNAs), has another activity by pausing at gene promoters. The paused
Pol II generates short 5’-capped RNAs of about 50 nucleotides in length. Much is
known about Pol II pausing including its prevalence across the genome, but the
molecular mechanisms that are involved in regulating Pol II pausing and its roles
in gene regulation are yet to be fully explored. In this study, I have investigated
the molecular mechanisms that regulate dynamics of Pol II pausing in response
to gene activation.
The main goal of this study was to determine how cells respond to stimuli
by altering Pol II pausing states. To this end, we characterized changes in Pol II
pausing in MCF-7 human breast cancer cells using two distinct stimuli, heat
shock and Trichostatin A (TSA), a histone deacetylase inhibitor. Two genes,
SNAI1, a master regulator of epithelial to mesenchymal transition, and HSPA1B
(heat shock protein 70), a master regulator of heat shock response, show mRNA
upregulation upon treatment with both stimuli. To determine changes in Pol II
pausing and its dynamics in response to gene activation, I have used
permanganate footprinting for single gene analysis, and short-capped RNA
sequencing (scRNA-seq) for genome-wide analysis. I have shown that, upon
activation, paused genes can retain Pol II pausing and non-paused genes can
acquire Pol II pausing. Further, I observe that genes such as HSPA1B undergo
xv

pause release during heat shock activation but SNAI1 does not. In addition, I
have shown that the turnover of the paused Pol II complex changes in a
stimulus-specific manner, indicating that the release of paused Pol II is sensitive
to the nature of the stimulus. To investigate the rate of turnover of the paused
complex, I used a specific inhibitor of a general transcription factor TFIIH,
Triptolide, and measured the residence time of the Pol II complex at the paused
site. Genome-wide analysis of Pol II turnover demonstrates that not all genes
respond the same way to heat shock. This project describes a novel mechanism
for regulation of transcription during gene activation in human cells in response to
environmental stresses.
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CHAPTER I
INTRODUCTION
1.1 Eukaryotic Transcription
Gene expression in eukaryotes is a tightly controlled, complex process
regulated by numerous transcription factors and enzymes. Chromatin-associated
proteins such as histones and non-histone proteins are involved in compacting
the genome, which is about 2m long in humans, into a confined space in the
5 μM nucleus. Dynamic interactions of chromatin with a variety of cellular factors
such as histone modifying enzymes and histone chaperones, ATP dependent
chromatin remodelers, activate and/or repress gene expression.
Eukaryotic transcription is a precisely timed process where multiple
proteins come together to synthesize RNA from appropriate genes. All
messenger RNA (mRNA) in eukaryotes are transcribed by the multi-subunit
enzyme RNA Polymerase II (Pol II). Transcription by Pol II occurs via three major
steps: transcription initiation, elongation and termination. Recruitment of Pol II to
promoters (transcription initiation) was long considered as the main regulatory
step of transcription in higher organisms.
1.2 Transcription Initiation
Transcription is initiated at the promoter DNA elements, which involves
sequential binding of general transcription factors (GTFs), TFIIA, TFIIB, TFIID,
TFIIE, TFIIF, and TFIIH (Matsui et al. 1980), together with Pol II, forming the
1

pre-initiation complex (PIC) (Figure 1). The formation of PIC is also dependent on
chromatin remodeling, which involves modifications of histones in the promoter
region (Kadonaga 2004). It has been suggested that histone modifications and
other chromatin marks play a regulatory role in highly transcribing genes (Vakoc
et al. 2005). The binding motifs of GTFs promote the assembly of the PIC by
facilitating DNA-protein and protein-protein interactions. Once the PIC is
established, Pol II together with other transcription factors (Pol II complex) can
proceed with transcription. There are multiple events during early transcription
that play regulatory roles. Pausing of Pol II and premature termination of
transcription in promoter-proximal regions are two of such steps that will be
discussed later in this chapter.

Figure 1.

A schematic diagram showing an overview of transcription. Pol II
gets recruited on to the promoter region along with other general
transcription factors to initiate transcription. Transcription is initiated
at the transcription start site (TSS), indicated by a black arrow. After
transcribing about 50 nucleotides from the TSS, Pol II pauses thus,
producing a short capped RNA. Once paused, Pol II can proceed
into elongation. During the elongation step the mRNA molecule
gets synthesized. Once the Pol II complex reaches the transcription
end site (TES), it undergoes termination dissociating from the DNA
template and releasing the mRNA molecule.
2

1.3 Elongation
Apart from initiation, elongation also plays a critical step in gene
regulation. The carboxyl terminal domain (CTD) is the largest subunit of Rpb1,
the largest subunit of Pol II, undergoes extensive modification during elongation.
The CTD contains tandem heptad repeats of a consensus sequence of amino
acids -YSPTSPS that is evolutionary conserved across eukaryotes. Yeast has 24
repeats on the CTD of Pol II whereas humans have 52 repeats. The serine
residues of the CTD remain unphosphorylated during recruitment but undergo a
series of modifications post recruitment or Pol II to the promoter. The serine-5
residues on CTD are phosphorylated by the cyclin dependent kinase 7 (CDK7), a
subunit of TFIIH, during early elongation and pausing. Serine-5 phosphorylation
is assumed to destabilize the interaction of Pol II with promoter elements and
enhance the interactions with elongation factors, facilitating elongation. Transition
of the Pol II complex to active elongation occurs with the recruitment of the
kinases that phosphorylate the serine-2 residues on CTD. The serine-2
phosphorylated-elongating Pol II complex is capable of recruiting factors that are
involved in chromatin remodeling and mRNA processing (Peterlin et al. 2006).
The transition of the Pol II from paused state to the elongating state requires the
kinase activity of p-TEFb (Marshall and Price 1992, Marshall and Price 1995). A
second kinase comprised of cyclin K and Cdk12 or Cdk13 is also involved in
phosphorylation of CTD in the 3’-end of the gene (Bartkowiak et al. 2010;
Greifenberg et al. 2016). Hence, phosphorylation of the CTD plays a role in
determining the status of Pol II complex during transcription.

3

Another feature that changes along the gene body is the Pol II elongation
rate. The correlation between characteristics of the gene body and the rate at
which the polymerase is able to move through the gene has been extensively
studied. Elongation rates have been measured to be ranging from 1-4 kilobases
per minute (Ardehali et al. 2009; Hah et al. 2011). The rate of transcription has
been shown to vary depending upon the region of the gene: the elongation rate is
slowest at promoter regions and is increased across the gene body (Danko et al.
2013). A recent study showed clear differences in elongation rates in response to
two different stimuli, TNF-α and Estradiol (E-2), and an increased Pol II signal
was measured at exons. However, this study was unable to demonstrate a
common trend in Pol II elongation rate in exons (Danko et al. 2013). In mouse
mesenchymal stem cells, the elongation rate was found to be negatively
correlating with CpG content and exon content and positively with the active
transcription mark of H3K79me2 (Jonkers et al. 2014). This evidence highlights
both pausing and elongation as steps that are clearly regulated during
transcription.
Pol II elongation is tightly linked to chromatin modifications. For instance,
the Pol II associated factor (PAF) complex is physically associated with
elongating Pol II and recruits histone H2B ubiquitinating enzymes (Pokholok et
al. 2002; Wood et al. 2003). Also, the histone chaperone Facilitates Chromatin
Transcription (FACT) histone chaperone complex is required for nucleosome
assembly and is involved in recruitment of p-TEFb (Saunders et al. 2003; Wada
et al. 2000).

4

The rate of Pol II elongation has been proposed to influence cotranscriptional processes such as splicing (Howe et al. 2003; de la Mata et al.
2003; Shukla & Oberdoerffer 2012), 3′ end processing (Nag et al. 2007) and
termination (Hazelbaker & Buratowski 2012).
1.4 Transcription Termination
After completion of mRNA synthesis, Pol II dissociates from DNA at the
transcription end site (Figure 1). This final step in transcription allows recycling of
Pol II molecules for new initiation events. Most eukaryotic genes carry a highly
conserved poly A signal at their 3’ ends. Once the polymerase transcribes the
poly A tail, the processivity of the enzyme reduces markedly. In humans, several
complexes are known to facilitate transcription termination. The ser-2 hyperphosphorylated CTD of Pol II is involved in recruiting several protein complexes
that facilitate transcription termination such as cleavage and polyadenylation
specificity factor (CPSF), the cleavage stimulatory factor (CstF) and Poly (A)
polymerase (Kuehner et al. 2011). Both CPSF and CstF complexes are recruited
to predominantly ser-2 Phosphorylated CTD repeats of Pol II. In addition, CPSF
has been shown to bind to AAUAAA, the mammalian Poly A signal, and slows
down the Pol II complex to trigger termination of transcription at the 3’ termini of
genes. Termination factors are found proximal to transcription end sites.
However, recent studies have shown occupancy of such factors close to
promoter proximal regions leading to exciting discovery of premature termination
in promoter regions, which will be discussed in 1.7 (Figure 2).

5

Figure 2.

A scheme of pausing of RNA Polymerase II as a central
mechanism in regulating gene transcription. The dashed arrows
indicate the processes that occur at promoter proximal region.
Once Pol II (red pentagon) is recruited and starts initiation (the solid
black arrow indicates the transcription start site), it transcribed
about 50 nucleotides and pauses at most mRNA gene promoters in
the presence of NELF (blue). Once paused Pol II can either
proceed into elongation (grey arrow) with the action of factors such
as p-TEFb or dissociate from the DNA template undergoing
premature termination in the presence of factors such as XRN2
(brown). The short RNA and Pol II is dissociated from the DNA
template during premature termination where Pol II can initiate
more cycles of transcription.

1.5 Processing of mRNA during Transcription
In eukaryotes, mRNA that is produced by Pol II undergoes several
modifications. Most of these modifications occur co-transcriptionally and the
three main processing steps are 5’ capping, splicing of introns and addition of a
poly A tail at the 3’ end of the RNA.
1.5.1 Capping of Pol II Transcripts
5’ capping is exclusive to transcripts of Pol II and is the first modification
on the nascent mRNA. The cap structure is an essential feature of mRNA that
7

allows them to be recognized by translational machinery in the cytoplasm. During
the early stages of transcription, the CTD domain of Pol II is hyperphosphorylated at the ser-5 residue. A 7-methylguanosine cap (7 mG) structure
is added to the nascent mRNA soon after initiation, during the transcription of the
first 25-30 nucleotides (Jove & Manley 1984; Rasmussen & Lis 1993) by
recruitment of capping enzymes (McCracken et al. 1997). The process of
capping of the 5’ end of the RNA is an intricate three step process (Mizumoto &
Kaziro 1987).
In addition to 7 mG, multiple different cap structures have been observed
predominantly on RNA that are much shorter, less than 200 nucleotides, than
mRNA and also in virus RNAs. Some small nuclear RNA (snRNA) and small
nucleolar RNA have been shown to contain a trimethylated version of the 7 mG
cap structure; (2,2,7 mG) (Banerjee 1980). Some viral RNA species have been
shown to contain 2,7 mG, a dimethylated cap structure (HsuChen & Dubin 1976).
The capped structure has been shown to stimulate splicing of the nascent RNA
in vitro (Konarska et al. 1984; Edery & Sonenberg 1985) and in vivo (Fresco &
Buratowski 1996; Schwer & Shuman 1996). The capped structure recruits cap
binding proteins (CBP) 20 and 80 that are involved in splicing and transport of
mRNA to the cytoplasm. In addition, the capped structure can be recognized by
protein synthesis machinery of the cell. 5’ capped RNA binds to translation
initiation factor eIF4E, promoting translation (Sonenberg et al. 1978; Edery et al.
1988; Fresco & Buratowski 1996). Further, antibodies against these specific cap
structures can be used to immunoprecipitate the RNAs (Bochnig et al. 1987) that
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can be subjected to microarray analysis or sequencing in downstream
applications (Jia et al. 2007). The capped structure enables identifying transcripts
of Pol II, which allows quantification of RNA through multiple methods including
scRNA-seq (Nechaev et al. 2010; Samarakkody et al. 2015) and Pro-cap-seq
(Kwak et al. 2013; Mahat et al. 2016). These genome-wide techniques allow
visualizing Pol II transcription by specifically detecting RNAs that are protected at
the 5’ end by a cap structure.
1.5.2 Splicing
During transcription elongation, the intronic regions of the nascent RNA
are removed and the exons are joined to generate a mature mRNA in a process
termed splicing. Splicing allows extensive diversity of mRNA and proteins in a
cell to arise from the same sequence of the gene (Wang et al. 2008; Warns et al.
2016). About 95% of protein coding genes in the cell can undergo alternative
splicing (Pan et al. 2008; Wang et al. 2008). Committed factors involved in
splicing are recruited to perform co-transcriptional splicing of the nascent premRNA (Ardehali & Lis 2009) and this process involves extensive DNA-RNA,
DNA-protein and RNA-protein interactions. General splicing factors and small
nuclear ribonucleoproteins (snRNPs) interact with proteins that are specific to
certain DNA sequences, to form a multisubunit complex, the spliceosome. The
variations in splicing patterns are closely related to the chromatin architecture
and elongation rate of Pol II along the gene body (de la Mata et al. 2003; Fong et
al. 2014). Alternative splicing has been observed in many biological processes
such as development, cancer (Srebrow & Kornblihtt 2006) and also during
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cellular stresses (Pleiss et al. 2007). Large switching in splicing patterns during
progression of cancer generates protein variants that function during changes in
cell morphology and transcriptional programs (Warzecha & Carstens 2012).
Among cellular stresses, splicing has been shown to be abolished in response to
heat shock but not chemical stresses (Yost & Lindquist 1986; Bond 1988;
Biamonti & Caceres 2009), and can be rescued by the presence of elevated
levels of heat shock proteins (Yost & Lindquist 1986). Chemical stresses also
induce heat shock proteins. However, the splicing patterns and mechanisms are
vastly different between the two responses. The relations of variation in splicing
with different stimuli to early transcriptional event are yet to be explored.
1.5.3 Polyadenylation
Most mRNAs have a tail with multiple adenosine (A) residues at their 3’
termini, commonly referred to as the poly A tail. PolyA polymerase has been
identified as the enzyme involved in adding A nucleotides to the 3’ termini
(Darnell et al. 1971; Edmonds et al. 1971; Lee et al. 1971). Most mRNAs contain
a highly conserves hexanucleotide sequence, AAUAAA, approximately 10-30
bases upstream of the polyadenylation site. There’s a second GU-rich region,
approximately 20-40 bases downstream of the transcription end site. These two
sequences and the distance between them not only determine the site of poly A
addition (MacDonald et al. 1994; Takagaki & Manley 1997), but also the length of
the poly A tail (Chen et al. 1995). The poly A tail stabilizes the mature mRNA as it
is transported to the cytoplasm to be translated.
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1.6 Promoter Proximal RNA Polymerase II Pausing
Although recruitment of Pol II and formation of the PIC are essential
regulatory steps in transcription, another major step of regulation of transcription
is promoter proximal Pol II pausing. After transcribing about 50 nucleotides from
the transcription start site, Pol II stalls generating a small RNA with a 5’ cap
(Figure 2). Pausing was first characterized on heat shock proteins, mainly on
HSP 70 of Drosophila melanogaster, when transcriptionally active polymerase
was found within a narrow region at the gene promoter prior to the induction of
the gene, immediately downstream of the transcription start site (Gilmour & Lis
1986). Following this work, Pol II pausing was described in other cell lines
derived from higher organisms and on other genes, implying that Pol II pausing is
a widespread phenomenon among metazoans. Genome-wide studies on Pol II
pausing in mammals and Drosophila (reviewed in Adelman & Lis 2012) have
indicated that pausing occurs specifically at genes involved in developmentally
related pathways (Muse et al. 2007; Levine 2011), stimulus response,
maintenance of pluripotency and more recently at many metabolic genes
(Williams et al., 2015). Even though the exact biological function of Pol II pausing
remains largely unknown, its importance in regulating gene expression is no
longer questioned. Others have shown that Pol II may compete with the
nucleosome at the +1 position to maintain the promoter in an open configuration
(Gilchrist et al. 2008). Some alternative hypotheses that have been proposed are
that pausing functions as a checkpoint for the 5’ end processing of RNA and also
ensures proper formation and modifications on the Pol II complex itself (Adelman
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& Lis 2012). Promoter proximal pausing of Pol II has been shown to accompany
histone H3K4me3 in embryonic stem cells, implying the association of pausing
with active genes (Chopra et al. 2011).
A number of different factors have been identified to regulate various
stages of pausing such as establishment of pausing, escape of pausing and
more recently premature termination of paused Pol II complexes. The transition
from the paused state to productive elongation is closely related to the changes
in phosphorylation status of the CTD of the largest subunit of Pol II.
1.7 Regulation of RNA Polymerase II Pausing
Pol II pausing peaks between 35-50 nts from transcription start sites in
Drosophila (Nechaev 2010), mouse (Core 2014) and human (Samarakkody et al.
2015) cells (Figure 2). The similarity in the location of paused Pol II in different
systems implies conservation of pausing location across species. The biological
systems that are being employed have vast differences in promoter sequences.
Hence, an obvious question of the sequence dependency of Pol II pausing is not
supported by much evidence in human systems. Transgene experiments in
Drosophila identified both the distal and proximal regions of the Hsp70 gene as
promoting Pol II pausing and mutations in those sequences decreased levels of
paused Pol II (Lee et al. 1992). Mammalian genes display prominent regions of
repetitive CG nucleotides, also known as CpG islands, around their promoter
regions, whereas Drosophila genes lacks such a feature (Hoskins et al. 2011).
The presence of CpG islands brings in diverse proteins and protein complexes
that are involved in DNA methylation at the cytosine nucleotides of a CG pair.
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DNA methylation brings about changes in promoter architecture; deacetylation of
histone H4 and methylation of histone H3 Lysine 9 (Hashimshony et al. 2003).
Such changes in chromatin structure cause Pol II pausing to be different in
promoter regions across species (Core et al. 2008; Rozenberg et al. 2008). The
conservation of location of Pol II pausing across species is a consequence of
multiple regulatory proteins and complexes that act at promoter proximal regions
of genes irrespective of the DNA sequence. Among the most important problems
is to understand how factors involved in Pol II pausing, elongation and premature
termination integrate to produce a specific outcome; either a mature mRNA
through productive elongation or short transcript through termination.
Collectively, the ability of paused Pol II to take two routes makes it, potentially, a
decision-making point of gene expression during early elongation. The question
remains whether pausing at steady state is a rigid property of a gene or a
dynamic property reflective of a cell state.
1.7.1 Establishment of Pol II Pausing through
Negative Elongation Factor (NELF)
Pausing at promoter regions is enforced by two multisubunit complexes:
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor
(DSIF), which contains Spt4a and Spt5, and negative elongation factor (NELF,
containing subunits A-E). These two complexes bind through C/D subunits of
NELF complex (Sun and Li, 2010). The five subunits of the NELF complex are
thought to act synergistically since depletion of individual subunits leads to
diminished levels of the others (Gilchrist et al. 2008; Sun and Li, 2010). The E
subunit of the NELF complex contains arginine-aspartic acid dipeptide repeats
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and has been shown to directly interact with RNA (Yamaguchi et al. 2002). A
more recent study showed that the NELF complex may have at least 3 different
RNA-binding domains (Vos et al. 2016), which may enable NELF to facilitate
exchange of different RNA species competing either directly with each other or
acting allosterically. Interaction of NELF with enhancer RNA (eRNA) has been
shown to promote its release on early response genes and trigger release of
paused Pol II into elongation (Schaukowitch et al. 2014). However,
understanding of the functions of NELF and eRNA is limited thus far.
NELF is an essential factor and its depletion has shown to be
embryonically lethal (Amleh et al. 2009). In vitro, NELF does not appear to bind
to Pol II or DSIF alone but it is able to bind the Pol II-DSIF complex (Yamaguchi
et al. 2002). Apart from the DRB complex, subunits of NELF has been shown to
interact with multiple proteins and complexes in the nucleus such as the cap
binding complex (CBC) of RNA (Narita et al. 2007) and the NELF-B subunit has
been shown to associate with breast cancer susceptibility gene BRCA1 (Ye et al.
2001).
Given the role of NELF in inducing Pol II pausing, depletion of NELF is
expected to increase expression of genes due to removal of pausing as a
roadblock. However, studies show that depletion of NELF, contrary to
expectations, leads to decreased expression of many genes in Drosophila,
mouse and human systems (Gilchrist et al. 2008; Rahl et al. 2010; Sun & Li
2010). Moreover, NELF depletion decreases stability of paused Pol II (Henriques
et al. 2013), yet these complexes do not go into productive elongation in most
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genes (Core et al. 2012). NELF depletion in Drosophila cells was shown to affect
recovery from heat shock (Ghosh et al. 2011). Thus, NELF, or pausing, clearly
have roles other than gene repression, and remain to be investigated.
1.7.2 Escape of Pausing into Elongation:
Positive Transcription Elongation Factor b
Positive elongation factor b (p-TEFb) alleviates the transcription halt
caused by of DSIF and NELF by phosphorylating them and allowing Pol II to
enter into elongation (Figure 2) (Renner et al. 2001; Yamaguchi et al. 1999). pTEFb is a protein kinase that targets phosphorylation of ser-2 residues of Pol II
CTD (Price 2000) and is comprised of cyclin dependent kinase 9 (Cdk9) and
either Cyclin T1 (CycT1), Cyclin T2 (CycT2) or Cyclin K (CycK). p-TEFb is
sequestered by the evolutionary conserved non-coding RNA, 7SK small nuclear
RNA (snRNA) where the p-TEFb binding to the noncoding RNA is mediated by
HEXIM1 or HEXIM2, and the formation of this complex inhibits the kinase activity
of p-TEFb, thereby limiting the transition of promoter proximally paused Pol II into
productive elongation. There are a number of factors that modulate Pol II pausing
by regulating the localization of p-TEFb on a gene. Regulated release of p-TEFb
has been shown to modulate global control of cell growth, proliferation and cell
differentiation (He et al. 2006). A Yamanaka factor c-myc, an essential factor in
embryonic stem cell renewal and proliferation(Cartwright et al. 2005), has been
shown to bind p-TEFb in tumor cells (Gargano et al., 2007; Kanazawa et al.,
2003), and is involved in pause release, thus acting as a transcriptional activator
(Rahl et al. 2010). NF-kB is another transcriptional activator that recruits p-TEFb
to genes. Bromodomain containing protein 4 (BRD4) acts as an upstream
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activator by mediating the acetylated histone dependent recruitment of p-TEFb
(Gregoire & Yang 2005) to gene promoters. In addition, factors such NF-κB and
c-myc that act primarily on initiation, have been found to promote pause escape
into productive elongation (Barboric et al. 2001; Rahl et al. 2010).
In multiple previous studies, p-TEFb has been inhibited using small
molecule inhibitors including DRB (Chodosh et al. 1989) and Flavopiridol (FP).
FP is a highly potent inhibitor of CDK9 (Chao & Price 2001; Ni et al. 2004) that
leads to overall suppression of transcription genome-wide (Ni et al. 2008;
Jonkers et al. 2014) and increase in promoter proximal Pol II in majority of genes
(Henriques & Adelman 2013).
1.7.3 A Second Exit for Paused Pol II: Premature Termination
Once paused, instead of proceeding into elongation, Pol II complex can
dissociate from the DNA template, terminating transcription abruptly (Figure 2).
This premature termination of transcription yields a very short RNA transcript that
is less than 100 nucleotides in length. With emerging evidence of occurrence of
premature termination in biological systems, the molecular mechanisms and the
action of candidate cofactor are still being unraveled. Recent studies have shown
evidence of premature termination of transcription at the promoter proximal
regions in yeast (Terzi et al. 2011), in an HIV model (Wagschal et al. 2012) and
in human cell lines (Brannan et al. 2012). The mechanisms described in the
studies are not similar, which suggests that premature termination may be an
inherent feature of a promoter. For example, the Nrd1-Nab3-Sen1 termination
pathway described in yeast indicates that H3K4 trimethylation promotes
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termination. Other studies describe how termination factors such as TTF2 and a
5’ to 3’ exoribonuclease XRN-2 are recruited to promoter-proximal regions of
genes to initiate termination. Consistent with a functional connection between
termination and promoter proximal pausing, NELF has been shown to promote
recruitment of a factor PCF11, another termination factor, to promoter-proximal
regions in Human Influenza Virus (HIV (Natarajan et al. 2013). Taken together,
premature termination likely involves distinct molecular mechanisms that can act
through multiple proteins. How termination pathways are regulated during gene
activation remains to be explored.
1.8 Pause Duration
The conservation of location of Pol II pausing implies that similar
mechanisms are involved in determining the dynamics of Pol II pausing. DSIF,
NELF and p-TEFb have been identified to play a role in determining the
residence time of Pol II at the paused site, which is an important measure of
gene or promoter activity. Recent work suggests that additional factors, such as
Gdown1, the product of the POLR2M gene that renders Pol II responsive to
Mediator, and the general transcription factor TFIIF may also influence the pause
duration of the paused polymerase. These factors act by affecting the
vulnerability of the paused Pol II complex to undergo premature termination
(Cheng et al. 2012). Therefore, pause duration recapitulates the action of the
factors that are involved in maintaining and releasing paused Pol II. Yet, the
underlying molecular mechanisms remain unclear.
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To determine the residence time of the paused Pol II complex, the small
molecule inhibitor, Triptolide (TRP), has been used. TRP is an XPB/TFIIH
inhibitor (Titov et al. 2011) that prevents the generation of newly engaged Pol II
during transcription initiation by inhibiting melting of the DNA template. A time
course of TRP treatment enables determination of the half-life of the paused Pol
II complex. Published work has used a variety of methods such as Chromatin
Immunoprecipitation (ChIP) Sequencing (ChIP-seq), Global run-on sequencing
(Gro-seq), high resolution permanganate footprinting and optical imaging. The
pause duration of Hsp70 gene on Drosophila polytene chromosomes was
estimated at 5 minutes using an optical method. The strategy involved a GFPtagged Pol II and mCherry LacI bound Hsp70 transgene (Buckley et al. 2014). In
mouse embryonic stem cells the pause duration averaged at 7 minutes (Jonkers
et al. 2014). In another study in Drosophila S2 cells, pause duration was
estimated for 12 genes where the pause duration exceeded 15 minutes on some
genes (Henriques et al., 2013). A recent study using HCT116 cells showed that
some genes, when treated with low TRP concentration, had prolonged pause
duration, which exceeded one hour in the case of some genes like the early
response gene FOS (Chen et al. 2015). The functional significance of Pol II
pausing is to allow sufficient time to integrate regulatory inputs into transcription
and (Henriques et al., 2013) allowing proteins to interact and undergo post
transcriptional modifications.
The above-described dedicated factors help determine how fast Pol II is
transitioning through promoter regions. The activity of such factors causes
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alterations in pause duration. For example, absence of NELF causes direct
reduction in pause duration that enable fast promoter escape of upregulated
genes (Gilchrist et al. 2008). How these factors integrate during rapid cellular
responses, such as stress and other environmental stimuli, to enable survival of
the cell remains to be understood.
1.9 Research Direction
1.9.1 Transcriptional Responses during Cellular Stresses
Cellular responses to stress are evolutionarily ubiquitous and play
essential roles in survival of the cell and the organism (Lindquist 1986; Feder &
Hofmann 1999). A cell can be exposed to many stresses from the environment
such as osmotic pressure, change in pH, change in temperature, availability of
nutrient content and heavy metals etc. Such suboptimal conditions trigger
responses such as modifications on enzymes, alteration in metabolism, vesicular
trafficking but one of the most upstream effects is change in gene expression.
Gene expression changes are associated with changes in chromatin
architecture; changes in nucleosome structure and positioning, regulation of
specific transcription factors, and activation or repression of transcription on
specific genes.
A cell responds to stress by activation of specific stress response
pathways through activity of transcription factors and upregulation of specific
genes. The ability to change specific biological pathways in response to stimuli
enhances the chance of survival of a cell. Defects in various stress response
pathways have been shown to associate with diseases such as cancer, diabetes
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(Oyadomari et al. 2002), Alzheimer’s disease (Terro et al. 2002), Parkinson’s
disease (Imai et al. 2001), etc. Defects in the heat shock response pathway
compromised early development in mice (Xiao et al. 1999), and overexpressing
the heat shock transcription factor in Caenorhabditis elegans results in increased
longevity (Garigan et al. 2002; Lund et al. 2002).
1.9.2 Gap in Knowledge
The dynamics of pausing and pause release remains largely unknown. It
is intriguing to look into the dynamics of pausing and pause escape of the Pol II
complex specifically during rapid transcriptional responses. This will determine if
the molecular mechanisms involved are common across the genome, or if they
are gene specific. While multiple studies have shown pausing and pause
duration to possibly be gene specific, the mechanisms involved in such
regulation remain to be characterized. In this study, I have explored pausing and
pause duration in MCF-7, a human breast cancer cell line, in response to two
activating signals, Trichostatin A (TSA) and heat shock. TSA is a compound that
has been shown to upregulate mRNA expression of the SNAIL gene (SNAI1) in
MCF-7 cells. SNAI1 is a master regulatory gene that is important in epithelial to
mesenchymal transition (EMT). In addition, I have used SLUG (SNAI2) and Ecadherin (CDH1) genes which are also involved in EMT. The second activator,
heat shock, has been extensively used in the field, as it was the first system
where Pol II pausing was first observed. This is the first time two activators were
tested on the same gene and further, the first time that dynamics of two genes
are compared in the same cells.
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1.9.3 EMT
EMT is a common biological process that occurs during embryonic
development. During EMT cells migrate during several major milestones in
development including gastrulation and neural crest formation where epithelial
cells transition to a more mesenchymal morphology. During EMT, vast changes
occur in the extracellular matrix, plasma membrane and cell morphology. During
EMT, matrix metalloproteinases that degrade the extracellular matrix and cell
surface proteins leading to release of promigratory factors making cells more
migratory and invasive (Derycke & Bracke 2004). The major characteristic of
EMT is loss of the cell junction protein CDH1 on the plasma membrane. SNAI1
has been described as a repressor of multiple target genes in human and nonhuman cells lines including cancer cells. In human cancer stem cells, SNAI1 is
shown to regulate the expression of a number of genes including IL-8 to induce
metastasis in cells (Hwang et al. 2011). Overexpression of SNAI1 has been
associated with recurrence of breast cancer (Moody et al. 2005) and hence much
attention is drawn towards SNAI1 to understand its role in cancer metastasis.
In addition to its effects on chromatin, TSA has been reported to increase
reactive oxygen species in a cell via kinase pathways (Rosato et al. 2003; Ruefli
et al. 2001). Moreover, TSA is known to activate several signaling pathways that
induce cellular stress such as NF-κB, MAPK and PI3K (Mayo et al. 2003; Ozaki
et al. 2006; Yu et al. 2007; Ruefli et al. 2001). Taken together, TSA may act as
an agent that induces cell stresses following short-term treatment.
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1.9.4 Heat Shock Response
The specific protein factors that are involved in heat shock response
(HSR) are broadly studied. HSR is an essential part of cell homeostasis that
ensures cell survival. Upregulation of heat shock genes provides the cell with
temporary enhanced tolerance to stress (Lindquist 1986; Sørensen et al. 2003).
HSR is regulated by transcription factors heat shock factors (HSF). Vertebrates
have 4 transcription factors HSF1-4, but HSF-1 is considered the master
regulator of heat shock response. During HSR, HSF-1 trimerizes and binds to the
heat shock element (HSE) in the promoter region of genes such as Hsp70 which
results in gene upregulation by increasing promoter proximal pause release
(Mahat et al. 2016).
The key to transcriptional activation during HSR is the association of
p-TEFb with HSF-1 (Lis et al. 2000). Not all genes are activated in a HSF-1
dependent manner during heat shock. Hence, an interesting question would be if
genes that are activated by HSF-1 dependent and independent pathways show
different dynamics of pausing at gene promoters. More specifically, changes in
rates of premature termination and elongation are affected during gene activation
will be reflected in measurements of pause duration. Therefore, using pause
duration as a measurement we can determine if the mechanisms that act at the
pause site are global or specific to a cohort of genes. Secondly, we will be able to
determine if premature termination and escape into elongation act on the same
genes in a stimulus specific manner.
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1.9.5 Research Goal
The regulatory importance of Pol II pausing is not questioned in the field.
Yet, the roles that paused Pol II plays during transcriptional responses remain to
be explored. Many proteins are being identified as playing a role in Pol II
regulation, but how these proteins contribute to produce specific transcriptional
outcomes is still understudied.
In this study, I have first investigated levels of Pol II pausing on genes
during basal and activated conditions in response to two stimuli, TSA and heat
shock, in MCF-7 cells. Secondly, I have looked at Pol II pausing duration as a
measure of dynamics of the paused Pol II complex during gene activation to
determine if the molecular mechanisms that are involved during gene activation
are common among genes. Finally, using sc-RNA sequencing I have
investigated levels of Pol II pausing and changes in pause duration genome-wide
to determine the global dynamics of Pol II pausing upon gene induction.
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CHAPTER II
MATERIALS AND METHODS
2.1 Cell Culture and Treatments
The cell line used in this study, MCF-7, is a human breast cancer cell line
derived from a metastatic site by pleural effusion of a 65 year old female. MCF-7
cells were obtained from American Type Culture Collection (ATCC® HTB-22™)
and were cultured in DMEM/F-12 medium (Life Technologies) with 10% fetal
bovine serum (Gibco). The growth medium was replaced every three days. Cells
were maintained in a humidified incubator at 37οC and 5% CO2.
Heat shock was carried out at 42οC for 30, 60 and 120 minutes. Cells
were treated with Trichostatin A (Sigma) at a final concentration of 1μM for 3
hours and beta estradiol (Sigma) at 10 nM for 1 hour in phenol red free DMEM/F12 supplemented with 10% charcoal dextran treated, heat inactivated FBS
(Atlanta Biologicals) and human insulin, human transferrin and sodium selenite
(ITS) (Sigma). Treatments with Triptolide (TRP) (Sigma) and Flavopiridol (FP)
(Sigma) were carried out after the above-described activations. TRP was used at
a final concentration of 2.5 μM and FP at 5 μM.
2.2 RNA Extraction
Total RNA was extracted from cells using the Qiashredder and RNeasy kit
(Qiagen). 500ng of RNA was run on a 1% agarose gel with TAE buffer to check
the integrity of each sample. 1 μg of total RNA was used in reverse
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transcription with SSRTIII reverse transcriptase (Invitrogen) with random
hexamer (Invitrogen) priming. The cDNA was then subjected to quantitativereal
time PCR using gene specific primers and all samples were normalized against
GAPDH gene. All data points are averages of three biological replicates with
standard error of the mean. Once validated, the RNA was checked again for
integrity and sent for RNA sequencing.
2.3 Permanganate Footprinting
Treatment of cells with potassium permanganate and all subsequent
reactions were performed as described previously for mammalian cells
(Samarakkody et al. 2015). All treatments with potassium permanganate were
done on freshly treated cells after washing with PBS buffer. Cells pellets were
resuspended in 50 μL PBS buffer, and then treated with 300 μL of ice cold 20
mM KMnO4 for 1 minute and the reaction was immediately stopped with 400 μL
of stop solution (20 μL of 5M NaCl, 100 μL of 1M Tris-HCl pH 7.4, 300 μL of βmercaptoethanol (Sigma), 400 μL of 500 mM EDTA and 500 μL of 10% SDS).
The cell lysate was treated with 3 μL of RNA cocktail (Ambion) at 37οC for 30
minutes and Fungal Proteinase K (Life Technologies) overnight at 56οC. 6 μg of
purified DNA was treated with piperidine (Sigma) in 100 μL and extracted twice
with chloroform. 250 ng of piperidine treated DNA was used in primer extension
with a gene specific primer A using Phusion high fidelity polymerase (Thermo
Scientific) and Hight Fidelity (HF) buffer. Subsequently the single stranded DNA
were ligated to a double stranded linker A’:B overnight at 16οC in the presence of
T4 DNA Ligase (ThermoScientific). The DNA was amplified after ethanol
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precipitation with gene specific primer B and universal linker A primer for 22
cycles and an additional two cycles of PCR with 32P radioactively labeled gene
specific primer C. The reaction was phenol-chloroform extracted, ethanol
precipitated and run on a denaturing 7% urea TBE gel.
2.4 Immunoblot Assay
Cellular extracts were prepared in lysis buffer (8M urea and 1M Tris HCl
pH 8.0) with protease inhibitor cocktail (Sigma). Total cell extracts were run on a
10% SDS-PAGE resolving gel alongside full-range rainbow marker (GE
Healthcare Life Sciences) and transferred onto a PVDF membrane using
standard technique of wet transfer under chilled conditions. The blot was then
blocked in 5% milk in TBS buffer with 0.1% tween for one hour and
immunoblotted against anti-RNA Polymerase Ser-2 (Millipore), anti-Actin (Life
Technologies), anti-cMyc antibody (Abcam ab32072) overnight at 4 οC. The blots
were then incubated for one hour with the horse radish peroxidase (HRP)
conjugated secondary antibody (GE Healthcare Life Sciences) at a dilution of
1:10,000. The blot was then treated with Luminata Forte Western HRP substrate
(EMD Millipore) for 5 minutes before imaging on the Odyssey imager.
2.5 Depletion using siRNA
siRNA sequences for XRN-2 and NELF were selected through the
Silencer Select tool by ThermoFisher Scientific and those for CDK9 was used as
previously published and CDK-9 antibody (A303-493A-M) from Bethyl
Laboratories (Yu et al. 2015). The siRNA was diluted in a 1:1 mix of
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Lipofectamine-3000 and Opti-MEM to a final concentration of 10 nM. The cells
were plated at a density of 60% and grown for 72 hours.
2.6 In vitro Synthesis of Capped RNA
DNA sequences were designed based on the mouse genome with 30-75
nucleotides in length, having a G nucleotide as the start with the T7 promoter
sequences at the 5’ end. The designed template sequence was to ensure that it
did not match to the human genome using the BLAT tool on the UCSC genome
browser (Kent 2002)The whole DNA sequence together with the T7 promoter
sequence was considered as the forward sequence which would serve as the
sense strand during subsequent in vitro transcription. The forward and the
complimentary reverse strands were mixed at a final concentration of 10 μM in
TE buffer in a total of 100 μL and annealed with a program ramping down from
95οC to 4οC. The reaction was then precipitated with 3 volumes of ethanol and 6
μL of 5M NaCl. Using 1 μg of the annealed DNA template the in vitro
transcription reaction was set up using the T7 Megascript kit (Ambion) as
recommended and incubated overnight at 37οC. The reaction was then treated
with 1 μL of TURBO DNase as recommended and the reaction was stopped by
adding the ammonium acetate solution as recommended. Then the RNA was
extracted using acid-phenol/chloroform and then again with chloroform before
precipitating with 3 times the volumes of ethanol. Then the RNA was then
precipitated at -80οC for at least 30 minutes and pelleted using a cold centrifuge
at maximum speed for 20 minutes. The RNA pellet was washed with 80%
ethanol, air dried to remove residual ethanol, and resuspended in 20 μL of water.
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The RNA was then mixed with an equal volume of 2X gel loading dye provided
with the Megascript kit and heated at 65οC for 5 minutes. The RNA was then
loaded on a 15% Urea-TBE gel that was pre-run for 20 minutes alongside the
single stranded RNA marker (NEB) and run at 200 V until the dye front reaches
the bottom of the gel. The band that corresponds to RNA of the expected length
was extracted from the gel and extracted using the crush and soak method,
where the gel pieces were placed in a gel breaker tube (Agilent) that’s placed in
a 1.5 mL Eppendorf tube and spun at 12000g for 5 minutes. The crushed gel was
then shaken at room temperature in 400 μL of 300 mM NaCl for 4 hours. The gel
homogenate was then spun through a 0.22 μM filter column (Agilent) for
5 minutes at 2000g. The flow though was then precipitated with 3 volumes of
ethanol and incubated in -80οC for 30 minutes before spinning at maximum
speed in a cold centrifuge to pellet the RNA. The RNA was washed in 80%
ethanol and resuspended in 20 μL of nuclease free water. A microliter each of
this RNA was quantified using both the Nanodrop and the Bioanalyzer
instruments.
A 7-methylaguanylate capped structure was added to the 5’ end of these
RNA using the Vaccinia capping system (NEB). The RNA was first heated at
65οC for 5 minutes and immediately placed on ice. Then to 15 μL of the gel
extracted RNA was combined with 2 μL of 10X capping buffer, 1 μL 10mM GTP,
1 μL of 2 mM SAM after dilution and 1 μL of Vaccinia capping enzyme was
added and incubated at 37οC for one hour. The capped RNA was then extracted
using acid-phenol/chloroform as described above.
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The efficiency of capping of each capped RNA was then checked using
the following four reactions where 200 ng of RNA was used in each reaction:
Reaction A: Treatment with 5’ phosphate dependent RNA polyphosphatase
(Epicentre)
Reaction B: Treatment with 5’ phosphate dependent RNA polyphosphatase
(Epicentre) followed by Terminator exonuclease (Epicentre)
Reaction C: Treatment with RNA 5’ Pyrophosphohydrolase (NEB)with followed
by Terminator exonuclease (Epicentre)
Reaction D: Treatment with RNA 5’ Pyrophosphohydrolase (NEB) alone
These four reactions were performed for each in vitro RNA and then was
mixed with equal volume of gel loading buffer II (Ambion). The RNA was then
loaded directly on a 15% Urea-TBE gel that was pre-run for 20 minutes and the
gel was run at 200 V. A successfully capped RNA will be retained after all
reactions except for reaction D, and if RNA is not reliably capped, there will be a
decrease in reactions B and D. The capped RNA was diluted such that when
added to the nuclei or chromatin in Trizol, the in vitro-synthesized RNA was in
the range of 10-50 molecules per cell.
2.7 Short Capped RNA Library Preparation
MCF-7 cells from different treatment points were used in the library
preparation using approximately 108 cells in two 15 cm dishes at about 90%
confluency. Cells were harvested and washed with 1X PBS buffer prior to nuclei
isolation.
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2.7.1 Nuclei Isolation
Cells were directly resuspended in 2 mLs of the cell lysis buffer (Williams
et al. 2015) containing 10 mM Tris-HCl (pH 8.0), 200 mM Sucrose, 3 mM CaCl2,
2 mM MgCl2, 0.1% Triton X-100, SUPERase In RNase Inhibitor (Ambion), and
Proteinase Inhibitor Cocktail (Sigma-Aldrich). The cell lysate was incubated on
ice for 10 minutes and further lysed in a douncer with 20 strokes. The lysate was
centrifuged at 1000 g in a cold centrifuge for 10 minutes to precipitate the nuclei
and the nuclei was washed to remove traces of cytoplasm. 5% of the cell
fractions were used in immunoblotting and qRT PCR analyses to confirm the
reliability of fractionation.
2.7.2 Chromatin Isolation
Cells from two 15 cm dishes at about 80% confluency were scrapped in
media and washed twice in cold PBS. The cells were resuspended in 10 mL of
swelling buffer (10 mM TRIS-Cl pH 7.5, 2 mM MgCl2 and 3 mM CaCl2) and
allowed to swell on ice for 5 minutes. Centrifuge at 2000g for 10 minutes and
then remove the supernatant. Resuspend cell in 1 mL of Lysis buffer (10 mM
TRIS-Cl pH 7.5, 2 mM MgCl2, 3 mM CaCl2, 0.5% Igepal, 10% Glycerol, 2 units of
Superase In) and gently pipette 20 times to lyse the cells. The lysate was brought
up to 10 mL and the nuclei pelleted by centrifuging at 2000 g for 10 minutes. The
isolated nuclei were resuspended in 125 μL of NUN1 buffer (20 mM TrisHCl pH
8.0, 75 mM NaCl, 0.5 mM EDTA, 50% Glycerol and Proteinase Inhibitor 100x
(Sigma)), followed by 1.2 mL of NUN2 buffer (20 mM HEPES-KOH pH 7.6, 7.5
mM MgCl2, 0.2 mM EDTA, 300 mM NaCl, 1M Urea, 1% NP40 and Proteinase
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Inhibitor 100x (Sigma)). The nuclei were incubated for 15 minutes on ice for
complete lysis while vortexing for 5 seconds every 4 minutes at maximum speed.
The chromatin was pelleted by centrifugation at 13,000g for 10 minutes in a cold
centrifuge.
2.7.3 Isolation of short RNA from Chromatin
and Nuclei Fractions
Nuclei or chromatin pellets were resuspended in Trizol to extract RNA with
subsequent chloroform extraction and ethanol precipitation. The RNA was
resuspended in nuclease free water, treated with DNase I (NEB) and incubated
at 37οC for 30 minutes. Then the reaction mixture was mixed with equal volume
of 2X gel loading buffer (Invitrogen) and heating at 65οC for 5 minutes. The
samples were loaded 20 μ g RNA per well on a 15% urea-TBE gel
10-well 1 mm thick gel (Invitrogen), alongside short range single stranded RNA
ladder (NEB), after pre-running for 20 minutes at 200 V. A section with short
RNAs between 20 to 80 nucleotides in length was cut from the gel and the RNA
was extracted using crush and soak method (Nechaev et al. 2010). The gel
pieces were crushed by placing them in gel breaker tubes (Agilent) inserted in a
1.5 mL Eppendorf tube and spinning in a bench top centrifuge at 12000g for
5 minutes. Then 400 μL of 300 mM NaCl was added to the crushed gel to extract
the RNA by shaking for 4 hours at room temperature. The gel slurry was then
transferred to 0.22 μ M spin filter tubes (Agilent) and spun at 2000 g for 5
minutes. The RNA was pelleted with 3 volumes of ethanol and 1 μ L of GlycoBlue
co-precipitant (Ambion) by incubating in -80 οC for at least 30 minutes before
spinning down at maximum speed in a chilled centrifuge for 20 minutes. The
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precipitated RNA washed with 80% ethanol and air dried prior to resuspending in
20 μ L of nuclease free water. One microliter each was used in quantification by
nanodrop and bioanalyzer 2100 (Agilent).
2.7.4 Library Preparation with small capped RNA
Approximately 700 ng of nuclear RNA and 300 ng of Chromatin bound
RNA was used in the library preparation protocol. 15 μL of size selected small
RNA was first denatured at 65οC and treated with 1 μL of T4 Polynecleotide
Kinase- 3’ phosphate minus (NEB) in the presence of 2 μ L of 10X T4
Polynucleotide Kinase buffer and 1 μL of Murine RNase Inhibitor (NEB) and 1 μL
of 10 mM ATP and incubated at 37οC for 30 minutes. This reaction would allow
phosphorylation of any degradation products at their 5’ end of the RNA. The
reaction was made up to 100 μL with nuclease free water (Ambion) and extracted
with 50 μL of acid-phenol/chloroform pH 4.5 with isoamyl alcohol, then with 50 μL
of chloroform and precipitated with 3 volumes of ethanol and 6 μL of 5M NaCl
and precipitated as described above. The RNA was resuspended in 17 μL of
nuclease free water and denatured at 65οC and immediately placed on ice. 2 μL
of 10X reaction buffer for 5’ RNA phosphate dependent polyphosphatase and 1
μL of 5’ RNA phosphate dependent polyphosphatase (Epicentre) was added to
the RNA and incubated at 37οC for 30 minutes. The reaction was precipitated as
described above and resuspended in 17 μ L of nuclease free water and
denatured at 65οC as described above. Then the RNA was treated with 1 μL of
Terminator Exonuclease (Epicentre) in the presence of 2 μ L of 10X reaction
buffer and incubated at 30οC for an hour and there after the reaction was
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precipitated as described above. The terminator exonuclease degrades RNA with
a 5’ monophosphate in a 5’ to 3’ direction.
Before the next step of ligating the 3’ adapter to the RNA, the adapter
sequence was preadenylated using the 5’ DNA adenylation kit (NEB) as
described in the NEB protocol. After the reaction was extracted with
phenol/chloroform with isoamyl alcohol (pH 7.5) (Sigma) and with Chloroform
(Sigma) and precipitated in the presence of 6 μL 5M NaCl with 3 volumes of
ethanol. The reaction was run through Bio-Spin 6 column (Biorad) as per
manufacturer’s instructions to remove remaining ATP.
After the reaction with Terminator Exonuclease the RNA was resuspended
in 7 μL of nuclease free water and mixed 1 μL of preadenylated 3’ RNA adapter
and incubated at 70οC for 2 minutes and placed on ice immediately. To the mix,
2 μL of T4 RNA Ligase buffer and 1 μL of T4 RNA Ligase 2, truncated K225Q
(NEB) and incubated at 28οC for 1 hour and 20οC for two hours. Then 10 μl of 2X
Gel loading buffer II was added, heated at 65οC for 5 minutes and loaded on a
15% Urea Polyacrylamide gel after pre-running for 20 minutes at 200 V,
alongside low range single stranded RNA ladder (NEB). Gel selection
corresponding to the RNA ligated to the 3’ adapter, 100-40 nucleotides was
excised and extracted from the gel using the cut and soak method as previously
described. The adapter ligated RNA was then resuspended in 18 μL of nuclease
free water and incubated at 37οC for 30 minutes with 1 μL of Murine RNase
Inhibitor and 1 μL of Shrimp alkaline phosphatase. The RNA was extracted with
acidic phenol/chloroform and ethanol precipitated as previously described. The
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RNA was then resuspended in 16 μL of nuclease free water and incubated at
37οC for 2 hours with 2 μL of 10X NEB Thermopol Buffer and 2 μL of RNA 5’
Pyrophosphohydrolase and extracted with phenol/Chloroform followed by ethanol
precipitation. RNA was then resuspended in 6 μL of nuclease free water and
denatured at 70οC for 2 minutes. The second ligation reaction for the RNA was
set up with 1 μL 10mM ATP, 1 μL of RNA 5’ adapter, 1 μL of Murine RNase
Inhibitor and 1 μL T4 RNA Ligase 1 (NEB). The ligation reaction was incubated at
28οC for an hour and 20οC for 2 hours. After the ligation of the 5’ adapter the
reaction was directly used in reverse transcription. 1 μl of 50 mM TruRT primer,
5X First strand synthesis buffer (Invitrogen), 0.1 mM DTT (Invitrogen), 12.5 mM
dNTPs and SSRTII (Invitrogen) was added directly to the reaction tube after
ligation and incubated at 50οC for one hour. After reverse transcription, 10 μL of
5X Phusion buffer, 2 μL of TruRTP primer and 2 μL of TruTPI indexed primer
was used in PCR with high fidelity Phusion polymerase (ThermoFisher Scientific)
The thermal program used was as follows; initial denaturing step of 94οC for
30 seconds, 16 cycles of 94οC for 15 seconds, 62οC for 30 seconds and 70οC for
15 seconds and a final extension at 70οC for 5 minutes.
Each library was mixed with 10 μL of 6X purple gel loading dye (NEB)
after the PCR amplification and directly loaded in two wells of a 6% nondenaturing polyacrylamide TBE 1mm thick gel (Invitrogen), alongside 25 base
pair DNA ladder (NEB) and run at 100 V until the dye front reached the bottom of
the gel. The library between 200-150 base pairs was cut from the gel and
extracted with 400 μL of 300 mM NaCl using the crush and soak method.
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The final library was resuspended in 20 μL of nuclease free water and a
microliter was used in both Nanodrop and Bioanalyzer quantification. Prior to
sequencing the inserts of libraries were validated by ligating about 30 ng of the
gel selected purified library to pBlueScript vector, that was dephosphorylated,
using T4 DNA ligase (ThermoFisher) followed by transforming the ligated DNA
into DH5-α Escherichia coli competent cells. Plasmids from 12-15 individual
clones with inserts were sequenced and the inserts were confirmed using the
BLAT tool on the UCSC genome browser (Kent 2002). The scRNA libraries were
sequenced on the Illumina MiSeq sequencer at the UND Epigenetics and
Bioinformatics Core using the RNA LT option in 50 base pair reads in a paired
end mode, using V3 150 cycle MiSeq kit.
2.8 Data Analysis
2.8.1 RNA-seq Analysis
The fastq files from the RNA-seq data were aligned to the human genome
(hg19) using topthat:
tophat2 -p 5 -o <folder_name> --transcriptome-index=transcriptome_data/ -G
genes.gtf genome sample.fastq.gz 2> ./ sample.stderr
The output sam file was converted to bam format, sorted, indexed and
used in R to generate a list of genes with differential expression using custom
scripts:
samtools sort sample.bam -o sample.BAM
samtools index sample.BAM -o sample.bai
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The differential expression was determined at p value of 0.01 using 2 replicates
for each time point of heat shock.
2.8.2 scRNA-seq Analysis
The paired end mode generates 2 fastq files containing the sequenced
reads; read 1 (R1) and read 2 (R2). Due to the RNA insert is fairly short, during
sequencing the adapters also get sequenced. Hence, the sequences were first
trimmed for the adapter sequences using cutadapt (Martin 2011). The adapter
trimmed files were then aligned with the hg19 human reference genome from
UCSC genome browser using the version 1.1.1 of bowtie (Langmead et al.
2009). The alignment was done with 2 allowable mismatches and the reads that
had non-unique alignments to the genome ware disregarded (Scheidegger et al.
2015). The unaligned sequences were output into a separate fastq file and
generated a bowtie file using the following command:
bowtie -p 6 -q -m 1 -n 2 --un sample_un.fastq
/local_storage/annotation_db/Homo_sapiens/UCSC/hg19/Sequence/Bowti
eIndex/genome sample sample.bowtie
From the aligned file of bowtie, an unbinned bedgraph file was generated
for visualization on the UCSC genome browser using the perl script
bowtie2bedgraph script as published (Scheidegger et al. 2015).
bowtie2bedgraph.pl sample sample /local_storage/annotation_db/Homo_
sapiens/UCSC/hg19/hg19_chrominfo.txt
R1 reported the 5’ end of the RNA, corresponding to the transcription start site,
and the R2 the 3’ end, equivalent to the pause site for short RNAs coming from

36

paused Pol II. For each sample of the scRNA fastq file, four bedgraph files were
generated separating the forward and reverse strand for each R1 and R2 in the
paired end format; R1_forward, R1_reverse, R2_forward and R2_reverse. These
bedgraph files were normalized using the counts of in vitro synthesized spike-in
RNAs in each sample, assuming that RNA losses of those RNAs through the
processes of RNA extraction and library preparation across samples are the
same. Spike-in RNA counts for each spike-in sequence was counted in each
fastq file using the following command where <sequence> would be the actual
sequence of the spike-in RNA:
grep -A 2 -B 1 <sequence> sample.fastq | sed '/--/d' > output.fastq.gz
zcat output.fastq.gz | echo $((`wc -l`/4))
The normalization for bedgraphs were performed by normalizing the counts for
all the spike-ins across samples.
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CHAPTER III
RNA POLYMERASE II PAUSING IS RETAINED
DURING GENE ACTIVATION
3.1 Pol II Pausing at Basal Levels is Positively Correlated
with Levels of Transcription
The levels of Pol II pausing on different genes vary greatly across the
genome as shown by multiple genome-wide studies in both Drosophila and
mammalian systems (Zeitlinger et al. 2007; Muse et al. 2007). This prompts the
question whether Pol II pauses at basal conditions to allow rapid activation in
response to a stimulus. Recent evidence shows that genes that lack Pol II
pausing at basal levels are activated just as fast as genes that has significant
levels of Pol II pausing prior to induction (Lin et al. 2011; Gilchrist et al. 2012;
Chen et al. 2013). Moreover, genome-wide analysis of mammalian transcription
rates revealed that induction of paused genes in response to TNF-α in fact shows
a slight delay in activation (Danko et al. 2013). In Drosophila embryos, Pol II
pausing is present on many genes that are not subsequently activated during
development (Levine 2011). This evidence suggests that rapid activation is
unlikely to be the main reason for Pol II pausing. Another hypothesis was that Pol
II pausing may result in more synchronous activation of genes following a
stimulus (Boettiger & Levine 2009) and perhaps, at basal conditions as well. To
determine if pausing is coupled with productive transcription, we compared
expression levels of EMT related genes to levels of Pol II pausing in a panel of
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human cancer lines, selected based on their varying expression of SNAI1 at
steady state conditions; MCF-7 (human breast epithelial cancer cell line), A375
(human epithelial melanoma cell line), MDA-MB-231 (human breast epithelial
adenocarcinoma cell line), T47D (human mammary ductal carcinoma cell line)
and A549 (human lung carcinoma cell line). We used potassium permanganate
footprinting to detect Pol II pausing on promoters of three genes, Snail (SNAI1),
Slug (SNAI2) and E-Cadherin (CDH1) in comparison to their mRNA expression
levels. Potassium permanganate footprinting is based on a previously published
protocol (Gilmour & Fan 2009) that we further optimized for the analysis of
mammalian cells. Noteworthy are several features of pausing: first,
permanganate reactivity for each gene is present at the same location across cell
lines (Figure 3), suggesting that the mechanisms that regulate Pol II pausing in
these cell lines are similar. Second, Pol II pausing signal is higher with higher
levels of steady state gene expression, thus highlighting a fundamental
relationship between pausing and transcription in the absence of activation. The
differences in levels of pausing and transcription across cell lines are, perhaps, a
result of differences in chromatin architecture, which determines how accessible
the promoter regions are.
3.2 Pol II Pausing levels are increased with activation of the SNAI1 gene
SNAI1 gene is one of the highly paused genes in MCF-7 but is expressed
at low levels in MCF-7 cells (Dhasarathy et al. 2007), indicating that perhaps
SNAI1 is poised for activation. Using several activating signals, we followed
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Figure 3.

Levels of Pol II pausing is associated with basal levels of
transcription independent of activation. (A) Permanganate footprints
for SNAI1, CDH1 and SLUG genes across different human breast
cancer cell lines demonstrate that high Pol II pausing signal
correlates with high levels of basal expression. (B) mRNA levels
analyzed in the same cell lines as shown in A. All values derive
from three independent experiments, and are plotted based on Ct
difference between the indicated gene and GAPDH.
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changes in Pol II pausing status on SNAI1 upon activation. We treated MCF-7
cells with 17β-estradiol (E2), a natural ligand of estrogen receptor alpha that was
previously shown to cause transient upregulation of SNAI1 in MCF-7 cells (Hah
et al. 2011), and followed a time course of transcriptional response (Figure 4A).
While MCF-7 cells showed an increase in SNAI1 RNA levels relative to GAPDH
control gene, we did not observe a change in the location of pausing with
activation, consistent with what was previously observed (Hah et al. 2011).
Further, the Pol II pausing signal did not change and, specifically, did not
decrease during the time course of gene activation as would be expected for
pause release (Figure 4A), consistent with previous data using Global Run-on
sequencing (Gro-seq) (Hah et al. 2011). However, the effect of E2 on MCF-7
cells is short-lived as demonstrated by another group (Danko et al. 2013). We
tested another system, a well-studied system of EMT that has been previously
shown to upregulate SNAI1 expression. We treated NMuMg,(Namru murine
mammary gland epithelial cells) with transforming growth factor beta (TGF-β).
SNAI1, a gene that is not paused in mouse cell lines gains Pol II pausing upon
treatment with TGF-β (Figure 4B). We then investigated the effects of the
compound Trichostatin A (TSA), a histone deacetylase inhibitor, that activates
SNAI1. Similar to activation with E2, activation of SNA1 gene transcription is
followed by an increase in Pol II pausing signal, which with TSA is the highest at
3 hours (Figure 4C). This response is not unique to MCF-7 cells, as SNAI1
mRNA also gets upregulated in response to TSA treatment of MCF-10 A (nontumorigenic human breast epithelial cell line).

41

Figure 4.

Pol II pausing signal is increased with gene activation.
(A). Permanganate footprint on SNAI1 gene with E2 treatment of
MCF-7 cells and mRNA fold change as detected by RT-PCR
normalized to GAPDH. RT-PCR represents an average of three
independent replicates. (B). Mouse NMuMG cells treated with TGFβ RT-PCR and permanganate footprinting represents an average of
three independent replicates. (C). MCF-7 cells treated with TSA.
RT-PCR represents an average of four independent replicates. The
regions of permanganate reactivity emerging during activation of
mouse Snai1 and human SNAI2 genes are shown alongside the
gel as a gray rectangle.
3.3 Pol II Pausing during Activation of SNAI1 Gene

The increase in Pol II pausing during gene activation is indicative of an
increase in Pol II occupancy at the promoter region. The increase in Pol II
pausing can be a result of increase in recruitment of Pol lI in response to gene
activation, or due to a decrease in residence time leading to high turnover of Pol
II at the paused site. At a given time, only a single molecule of Pol II can occupy
the paused site. Therefore, the increase in pausing during gene activation is due
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to more cells in the population gaining Pol II pausing on the SNAI1 gene due to
increased recruitment with activation. To investigate what fraction of cells, and
gene copies, in a population was occupied by paused Pol II on SNAI1 gene, we
used artificial templates based on the human SNAI1 gene sequence and
containing an artificial transcription bubble. By measuring permanganate
reactivity on artificial templates containing the known proportion of bubble, we
determined that permanganate footprinting faithfully reports the relative propotion
of bubbles on a gene. Based on 3 biological replicates we determined that the
Pol II occupancy increases by 2-fold during TSA activation using 3 independent
replicates. Given that TSA activation of MCF-7 cells leads to about 2 fold
increase in permanganate signal on SNAI1 gene, our data allowed us to
postulate a 2-fold increase in the fractional occupancy of the SNAI1 gene in vivo.
This means that the highly paused SNAI1 gene was not fully occupied prior to
activation and the occupancy at basal levels was less than 50%.
Next we sought to find if the activation of SNAI1 gene involves a change in
residence time of paused Pol II. To determine changes in residence time of Pol
II, we used TRP which specifically inhibits TFIIH (Titov et al. 2011). TRP inhibits
recruitment of Pol II and thereby allows us to follow the Pol II complexes that are
already paused (Henriques & Adelman 2013; Jonkers et al. 2014). We observed
that the TSA activation of SNAI1 gene (last four lanes of Figure 5A) does not
speed up the turnover of pausing (first four lanes of Figure 5A). We demonstrate
that the activation of SNAI1 by TSA does not involve changes in Pol II dynamics
and that the activation takes place through increase in Pol II recruitment and
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Figure 5.

The SNAI1 gene is activated through Pol II recruitment without
changes in Pol II pausing duration. A. Pause signal decays in the
presence of Triptolide (TRP). Quantitation of permanganate
footprints (below), from three independent experiments. B.
Permanganate footprinting of artificial bubble templates was done
with SNAI1 +100 primer set. A+G ladder and reactivity of MCF-7
cells, treated and untreated with TSA, is shown for comparison.
Permanganate shows linear response to the proportion of
transcriptional bubble. Quantitation of the experiment as in A. The
values were obtained from three experiments and represent the
area under the curve in the indicted part of the footprint.

transcription initiation events. This experiment demonstrates, for the first time,
that a gene can be transcriptionally activated without changes in pause duration.
Other genes, notably, HSPA1B heat shock protein 70 gene, have been shown to
change pause duration during activation in both Drosophila and mammalian
systems (Lis, 1998, Mahat et. al 2016). Our results point to a previously
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unsuspected role of pausing during transcriptional responses. To investigate if
the mechanisms involved in activation of SNAI1 gene with TSA are distinct
across cell lines, we followed activation in A375 cells, a human melanoma cell
line. We note that both SNAI1 and SNAI2 genes get upregulated upon treatment
with TSA (Figure 6A) in A375 cells just as they do in MCF-7 cells. Upon following
the dynamics of the paused Pol II complex we observe that TSA activation of
SNAI1 gene in A375 cells does not involve changes in pause duration.

Figure 6.

TSA activation of SNAI1 gene occurs through does not involve
change in Pol II pausing duration. A. mRNA fold change upon
treatment with TSA in A375 cells. B. Footprint for SNAI1 gene upon
TSA activation and C. the quantification plot of the relative footprint
in the presence of TRP.
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3.4 Context-Dependent Release of Pol II Pausing during Gene Activation
Transcription initiation and Pol II pausing are two key processes that
regulate early stages of transcription (Adelman & Lis 2012). Different signaling
pathways have been in principle shown to activate transcription through either
increase in initiation or release of pausing (Danko et al. 2013). However, this
study employed activation in two different cell lines; MCF-7 cells stimulated with
E2 and AC16 cardiomyocyte cells treated with TNF-α. Whether the same gene
could be activated through two distinct mechanisms of pause release, and
increase in Pol II recruitment in the same cell line was unknown. To follow
activation of the same gene by different stimuli, we studied the heat shock
pathway in MCF-7 cells, which upregulated the heat shock protein 70 (HSPA1B)
gene. As previously observed in Drosophila (Gilmour & Lis 1986) and mouse
systems (Mahat et al. 2016), we observed an increase in mRNA levels of
HSPA1B in MCF-7 cells (Figure 7A). Previous reports have demonstrated that
Pol II pausing gets completely obliterated in non-heat shock related genes in
Drosophila (Yao et al. 2006). In contrast, the SNAI1 gene remains paused during
heat shock activation of MCF-7 cells. These results suggest that heat shock
activation in mammalian cells is different than in Drosophila. We note that the
activation of HSPA1B by TSA depends on an increase in Pol II recruitment and
that activation by heat shock proceeds through pause release, demonstrating for
the first time that the same gene can be activated by distinct mechanisms
depending upon the stimuli (Figure 7B).
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Figure 7.

Pol II pausing is retained on HSPA1B gene during activation under
the conditions of pausing release. (A) Permanganate footprinting
for the time course of heat shock, shown for HSPA1B gene. The
region of pausing is highlighted in gray. (B) Activation of HSPA1B
gene with TSA (3 h) and heat shock (30 min), shown alongside
naked DNA and the A/G ladder.
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CHAPTER IV
PAUSING DYNAMICS DURING TRANSCRIPTIONAL RESPONSES REVEAL
REDIRECTION OF PAUSED RNA POLYEMRASE II
4.1 Activation with TSA Results in Robust Transcriptional
Response that is Common Across Cell Lines
To monitor changes in dynamics of Pol II pausing in response to stimuli,
we tested global transcriptional responses to two distinct stimuli. Firstly, we
chose TSA which has been previously shown to induce stress pathways. Gene
activation with TSA, unlike that with heat shock, is not known to involve a specific
transcription factor. To determine which genes were activated in response to two
distinct stimuli TSA and heat shock, we performed mRNA-sequencing (RNA-seq)
of MCF-7 cells following exposure to these stimuli. Among the time points that
were published for TSA, we chose the 3 hour time point, as it gave the highest
fold increase of SNAI1 mRNA. Using a fold change cutoff of 1.3 and stringent
criteria of adjusted p-value of less than 0.5, we identified genes that are
differentially expressed upon TSA treatment.
Activation with TSA leads to a robust change in transcription. A higher
number of genes are differentially expressed during TSA treatment of MCF-7
than in A375 cells (Figure 8). To investigate if transcriptional changes in
response to stress are specific to the cell type, we performed RNA-seq analysis
on A375 cells upon treatment with TSA. We observe that MCF-7 cells
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Figure 8.

A large number of genes undergo changes in transcriptional levels
during TSA treatment. Plot showing mean expression vs log fold
change in A375 (A), and MCF-7 cells (B). in response to TSA
treatment.
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are more responsive to TSA in terms of the number of cells that appear to be
differentially regulated upon TSA treatment relative to the control (Figure 9A and
9B). We observe that similar groups of genes are activated with TSA in both
A375 and MCF-7 cells as per Gene Ontology (GO) analysis (Figure 9C and 9D).
Thus, TSA treatment results in robust transcriptional responses despite the
variation across the two cell lines.
4.2 Heat Shock of MCF-7 Cells Differentially Regulates
Metabolism Related Genes
We next chose the heat shock response (HSR), a stress response
pathway active in cancer cells (Mendillo et al. 2012), which is well studied with
regards to Pol II pausing. HSR involves the recruitment of transcription factors
called heat shock factors (HSF)s, especially HSF-1, to the promoter regions of
some genes. During HSR not all genes are upregulated in a HSF-1 dependent
manner, indicating distinct mechanisms of gene activation with the same stimuli
(Mahat et al., 2016). We used 42οC for heat shock with 30, 60 and 120 minutes
as published for the SNAI1 and HSPA1B genes (Samarakkody et al., 2015).
We first sought to identify early response genes of the HSR and genes
that are upregulated later during heat shock. We observed a higher number of
genes that are upregulated than downregulated during HSR. In addition, more
genes are upregulated with longer duration of heat shock in MCF-7 cells. We
note that RNA sequencing is biased against downregulated genes relative to
nascent RNA analysis methods such as PRO-seq. PRO-seq is thus better suited
for detecting downregulated genes (Mahat et al. 2016), and can be used in future
work.
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Figure 9.

Metabolic processes are largely affected during TSA treatment of
both MCF-7 and A375 cells. Venn diagrams showing the number
of genes in MCF-7 (blue circle) and A375 (green circle) cells that
are upregulated (A) and downregulated (B) during TSA treatment.
Pie charts generated using the Panther program showing
categories of genes that are upregulated (C) and downregulated
(D) in both MCF-7 and A375 cells.
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The activation of genes following the HSR that we observe here is
consistent with what has been previously reported. The three genes upregulated
at 30 minutes of heat shock (Figure 7B), HSPA1B, HSPA1A and DNAJB1 (a heat
shock protein 40), are genes in the HSR pathway (Table 1 and Figure 10A).

Table 1. The number of genes that are differentially expressed during heat
shock response. The number of genes listed meet the criteria of adjusted
p-value of 0.5 and have a log fold change of greater than 1.3. Each data point
is representative of two independent replicates.
Upregulated genes
Downregulated genes
Heat shock 30 minutes

3

0

Heat shock 60 minutes

108

2

Heat shock 120 minutes

213

5

When cells were heat shocked for a longer period of 60 minutes,
108 genes, including HSPA1B, HSPA1A and DNAJB1, were upregulated. While
there were a larger number of genes that were significantly upregulated, 2 genes
(red dots in Figure 10B) appeared to downregulated. Among the upregulated
genes most genes are related to metabolism and other cellular processes (Figure
10C) as expected. At a longer time point with heat shock, more genes get
upregulated (Figure 10D). We also note that some genes get transiently
upregulated during heat shock. We note that 17 genes appear as differentially
expressed only at 60 minutes (Table 2) and 125 genes only at 120 minutes. Wellknown early response genes such as JUN and FOS are two examples of genes
that are significantly upregulated at 60 minutes but not at 120 minutes of heat
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Figure 10.

Genes involved in metabolism are upregulated during heat shock
response. Plot showing the average expression and fold change at
(A) 30 minutes, (B) 60 minutes and (D) 120 minutes Gene ontology
analysis of genes that are identified as differentially expressed
upon heat shock at (C) 60 minutes and (D) 120 minutes.

shock. These data provide evidence that some genes are activated early during
the stress response, and some genes are activated in a transient manner.
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Table 2. List of genes that are differentially
expressed only at 60 minutes. The list of
genes is sorted by the fold change and the
p value is adjusted to disregard genes that
have very low level of expression at basal
stage.
Gene
Fold
p value
Change
JUN
2.79
6.63E-06
PPP1R3C

2.78

1.01E-05

AP4B1-AS1

2.71

1.13E-05

RAET1K

2.41

0.000283347

PPP1R15A

2.38

0.000449711

ZC3H12A

2.38

0.000324101

FAM43A

2.28

0.000459722

FOS

2.26

0.00101959

ARC

2.23

0.001200184

DNAJB5

2.20

0.001553058

PSMD6-AS2

2.10

0.003984572

CIART

2.09

0.008118012

MYLIP

2.07

0.000161757

CCDC117

1.99

0.001246679

FRMD6

1.88

0.00493782

NUFIP2

1.77

0.009887267

DKK1

0.52

0.007441079
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CHAPTER V
POL II PAUSING MAINTAINS A BALANCE BETWEEN PRODUCTIVE
ELONGATION AND PREMATURE TERMINATION DURING
TRANSCRIPTIONAL RESPONSES
5.1 Turnover of the Paused Pol II Complex is Determined by the Stimulus
Escape of paused Pol II into productive elongation is essential in
producing mRNAs from a gene. The kinase activity of the p-TEFb complex,
which is composed of the cyclin-dependent kinase CDK9 and Cyclin-T,
phosphorylates the CTD of the large subunit of Pol II and facilitates the transition
to productive elongation. During activation of genes, two distinct mechanisms
come together to increase transcription: increased recruitment of Pol II to
promoter regions and increased activity of p-TEFb facilitating escape of paused
Pol II into elongation. Gene activation has been proposed to follow two distinct
mechanisms in response to E2 and TNF-α in two different cell lines (Danko et al.
2013). We have previously shown (Samarakkody et al. 2015), as demonstrated
in chapter 1, that genes can be activated by an increase in recruitment of Pol II
onto promoter regions without changes in pausing duration. This study
demonstrated that E2 increases Pol II initiation and TNF-α increases the escape
of paused Pol II into productive elongation. Although transcriptional activation of
E2 and TNF-α follows two distinct mechanisms, the inherent differences between
the two cell lines may have also contributed to the different responses, leaving
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the question of whether the same gene can be activated through the same
mechanism open. We next determined whether the response of paused Pol II to
gene activation is determined by the gene or by the stimulus. To do so, we
selected genes that are upregulated by both TSA and heat shock in MCF-7 cells.
If the mechanism of activation is determined by the gene, dynamics of paused
Pol II and hence the duration of pausing at a given gene will be the same with
different stimuli. However, if activation of a gene is determined by the stimulus,
the pause duration of a gene may be different depending upon the stimulus. To
determine pausing duration, we used Triptolide (TRP), as described in the
previous chapter, which has been used by us and others to measure pause
duration (Samarakkody et al. 2015; Henriques et al. 2013) at a final
concentration of 2.5 μM. We chose to investigate SNAI1 and HSPA1B genes that
are upregulated both with TSA and heat shock. We first compared how TSA
treatment affects activation of both SNAI1 and HSPA1B (Figure 11A-D). We
noted that the pause duration does not change with TSA treatment on both
tested genes. However, the pause duration is drastically reduced upon heat
shock treatment on both SNAI1 and HSPA1B (Figure 11E-H) indicating that
dynamics of the paused complex changes in a stimulus specific manner, and not
in a gene specific manner. During the heat shock response, the transcription
factor HSF-1 is known to be recruited to some promoter regions. HSF-1 can
recruit p-TEFb, a pause release factor. The HSPA1B gene is activated in an
HSF-1 dependent manner, but SNAI1 is not. The fast decay of Pol II at the pause
site in HSPA1B can be attributed to pause release that may occur in an HSF-1
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Figure 11.

Pause duration changes with heat shock and not with TSA
treatment. Permanganate footprints and quantification plots (right)
for SNAI1 (A) and (G) and HSPA1B (C) and (E) with TSA and Heat
shock in the presence of TRP. Each time point is an average of
3 independent replicates.
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dependent manner. However, it is yet to be explored whether the rapid decay of
the paused complex on the SNAI1 gene is due to pause release into elongation.
5.2 Pol II Turnover Increases Genome wide during Heat Shock Response
Knowing that two genes change dynamics of the paused Pol II in the
presence of heat shock, we next sought to address if it is a characteristic of a
cohort of upregulated genes, or is common across the genome. To investigate
Pol II turnover on genes across the genome, we used short capped RNA
sequencing. With modifications to the published protocol, we selected for short
capped RNA from the nuclei of MCF-7 cells to investigate genome-wide Pol II
pausing (Figure 12). Two genes that are known to be paused in MCF-7 cells,
SNAI1 and CDH1 genes, showed a signal with short-capped RNA sequencing
(scRNA-seq) while SNAI2, a gene that is not paused at delectable levels in MCF7 cells does not (Figure 12). Consistent with what has been previously observed
in Drosophila and mouse, we observe that Pol II pauses about 35 nucleotides
downstream of the transcription start site in humans (Figure 13).
To select for RNA that results from Pol II pausing, we fractionated cells to
obtain RNA that is bound to chromatin. Using a previously published protocol,
(Samarakkody et al., 2015) with modifications, we were able to reliably detect Pol
II pausing genome-wide using chromatin bound RNA. During the time course
with TRP the amount of chromatin bound RNA at the 20-minute time point is
expected to be low to none due to the decay of complexes from the paused site
(Figure 14). Hence, the libraries from these time points cannot be normalized
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Figure 12.

Pol II pausing on individual genes. (A). SNAI1 and CDH1 genes
show evidence of Pol II pausing but (B). SNAI2 gene does not. For
each gene, a UCSC genome browser view is shown, with positions
of Pol II ChIP-seq bins and the positions of 5′ and 3′-RNAs
indicated. For scRNAs, plus and minus strand matches are shown
as separate tracks. Numbers near each peak represent the
maximum number of sequence reads within the displayed interval.
An inset below each gene shows a zoomed-in view of scRNA
tracks around the TSS. Permanganate footprinting of the same
gene is shown on the right, alongside naked DNA and A/G ladder.
Annotated TSSs are shown with arrows and TSS start sites are
shown in green. The region of permanganate reactivity is shown
alongside the gel and on the gene scheme in purple. An asterisk at
the SNAI1 gene indicates a non-specific band present both in cells
and naked DNA.
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Figure 13.

(A) Heatmaps showing scRNAs for 7302 genes with the highest
promoter Pol II enrichment, in the region of ±500 nt around their
RefSeq (annotated) TSSs. The position of the TSS is shown by an
arrow. Only the sense strand scRNAs are shown. (B) Metagene
plot showing the frequency distribution of lengths of scRNAs based
on distances between R1 and R2 paired-end sequencing read
positions.

based on the total number of reads. To overcome this, we have used known
amounts of artificially synthesized short capped RNA, with known lengths and
sequences, which we added in to Trizol at the step of RNA extraction which are
then used in normalization.
We show that paused Pol II complexes decay in the presence of TRP
genome-wide as observed for SNAI1 and HSPA1B genes. Secondly, we note
that most complexes decay faster in the presence of TRP with heat shock
activation (Figure 15). For genes that are upregulated, the increase in turnover of
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Figure 14.

Chromatin bound RNA allows to detect decay of paused Pol II
complex genome wide. A HSPA1B and B SNAI1 I genes showing
decay of signal from R1 reads from scRNA-seq in the presence of
TRP.

paused complexes can be a result of more pause release in to productive
elongation to produce more mRNA. Alternatively, the high turnover can also be a
consequence of increased premature termination which could be especially true
for genes that are downregulated or not significantly upregulated during
activation. We also observe that a few genes such as FTL, SNHG1 and RPLP1
that show increased paused duration upon heat shock.
5.3 Pause Release by p-TEFb affects Pol II Turnover
Having observed that the fast release of paused Pol II is stimulus
dependent, we sought to answer if pause release completely relies on the activity
of p-TEFb. We used Flavopiridol (FP), a potent inhibitor of p-TEFb, to investigate
if paused Pol II complexes are released slower when pause escape is blocked by
FP. In fact, what we observed was a faster release of paused Pol II at basal
levels (Figure 16), indicating that the paused complexes may be actively
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Figure 15.

Heat map showing faster decay of complexes genome-wide in the
presence of TRP. The scale on the left shows the fold change of
signal and the genes are being ranked after unsupervised
clustering.

redirected towards premature termination when paused Pol II cannot proceed
into elongation. Next, we investigated how the dynamics of paused Pol II may
change during gene activation. Using TSA and heat shock as activators, we
followed paused Pol II in the presence of FP. We observe that with activation of
SNAI1 gene with TSA, the complexes showed faster turnover. We compared this
observation with heat shock activation and noted that the turnover rate of the
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paused complexes increased in the presence of FP. Hence, for the first time, we
show that the balance between productive elongation and premature termination
changes in a stimulus dependent manner.

Figure 16.

Inhibition of p-TEFb with FP shows a stimulus specific effect on
pausing duration. A. SNAI1 gene showing faster decay in the
presence of FP along with the quantification plot on the right B. C.
Gel image for SNAI1 gene in the presence of FP with TSA
activation with the quantification plot on the right D.

63

CHAPTER VI
DISCUSSION
The main objective of this study was to determine how Pol II pausing
could regulate transcriptional programs in cells in response to stimuli. Pausing
has been previously suggested to serve as a platform to integrate regulatory
inputs (Henriques et al. 2013) into a transcriptional outcome. However, the
mechanisms that involve multiple transcription factors and dedicated proteins in
regulating transcriptional outcome are not well understood. We demonstrate that,
firstly, Pol II pausing is retained during activation on genes with both TSA and
heat shock activation. Secondly, we show that genes can be activated through
distinct molecular mechanisms primarily through either pause retention or pause
release. Here, we show that the same gene can be activated by either increase
in Pol II pausing or by release of pausing depending upon the stimulus. This
demonstrates that genes are flexible in their response to stimuli and that
activation of the same gene can occur through distinct molecular mechanisms as
measured by pause dynamics. Regardless of the mechanism of activation, Pol II
pausing plays an important role in regulating the transcriptional outcomes.
Using global sequencing of scRNA to map Pol II pausing across the
genome in human MCF-7 breast cancer cells, we show that (i) transcription start
sites can be reliably detected by analysis of the 5’ ends of scRNA reads and
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(ii) the location of Pol II pausing can be detected by the 3’ ends. These studies
show that pausing location is highly conserved across the genomes of different
classes, Drosophila, mice, and as we show, humans. We note that, consistent
with what has been observed in other systems, the predominant distance of
33–35 nucleotides downstream of the TSS was observed across the genome on
MCF-7 cells, indicating that the underlying molecular mechanisms govern
pausing of Pol II regardless of the promoter sequence. Furthermore, using the
scRNA sequencing on RNA from chromatin-bound fraction, we were able to
detect pause duration on a global scale. We note that most genes show an
increased turnover at the paused site upon heat shock activation. Future studies
will determine if genes that demonstrate increased turnover also show increased
rates of premature termination and pause release upon heat shock as well as
other stimuli. Monitoring the dynamics of Pol II pausing in response to stimuli will
be used in future work to for profiling of cells perhaps during differentiation,
development and also during progression of diseases such as cancers.
The work characterizes several novel properties of Pol II pausing. First,
we demonstrate the plasticity that genes exhibit in response to different stimuli at
the level of pausing. We show that Pol II pausing continues to provide a stable
platform not only prior to, but also during transcriptional responses to stimuli. We
report for the first time that the dynamics of paused Pol II in response to
activation is not hardwired in the gene, but is dynamically determined by the
stimulus. Using model genes SNAI1 and HSPA1B, we show that the same gene
can respond to different stimuli differently and specifically, leading to faster
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release of paused Pol II with heat shock, yet retention of pausing with TSA. At
the conditions of fast turnover of Pol II during activation, the location of pausing
did not change, suggesting that all factors necessary for pause establishment
and release remain available at the promoter, even at conditions of high-level
activation. The mechanisms that involve pause release rely on multiple steps of
p-TEFb recruitment, phosphorylation of NELF, and the interaction or recruitment
of multiple functions through protein complexes such as the Super Elongation
Complex. While the interplay between pausing establishment and release across
the genome remains to be fully understood, our data show that Pol II pausing
remains the slowest step on heat shock gene in human cells even at the
conditions of high-level activation. Further analysis of early transcription
combining nuclear run-on and free RNA-based methods will shed light on the
mechanisms and global dynamics of pausing during stimulus response.
Using several EMT related genes such as SNAI1, CDH1 and SNAI2, we
show that gene activation can take place without changes in pausing location
and dynamics as measured by pause duration. Among these genes, SNAI2 is
considered a non-paused gene due to low levels of promoter Pol II observed in
cells prior to activation. In addition, SNAI1 and SNAI2 genes are transcribed at
very low levels in MCF-7 cells. The human SNAI1 gene upon activation with TSA
acquires pausing signature revealed by increased recruitment of Pol II to the
promoter. From a perspective of mechanisms, the availability of the negative
elongation factor (NELF) during each transcription initiation determines the
establishment of pausing (Gilchrist et al. 2008; Yamaguchi et al. 1999). During
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differentiation and development, the availability of factors such as NELF may
change, thus altering pausing status on genes. Overall, we propose that the
increase of the pausing signal represents the default outcome of gene activation
that enables context-specific regulatory inputs, one of which is pause release, to
affect the rate of mRNA synthesis. Further analysis of pausing in different
systems will uncover its role both in maintaining genes in a “poised” st
In Drosophila genes with high levels of Pol II pausing contain initially
transcribed sequences that favor nucleosomes and promote chromatin
assembly. In contrast, genes that have low levels of Pol II pausing on promoter
sequences disfavor nucleosome assembly (Gilchrist et al. 2010). In mammals,
Pol II pausing is enriched at genes that contain CpG islands at promoter regions
(Core et al. 2008). Although much debated, there is evidence supporting the idea
that, as in Drosophila, CG rich mammalian promoters favor nucleosome
formation, suggesting that pausing at such promoters helps maintain the
promoter in an open configuration to be readily accessed by the transcription
machinery. We note that human SNAI2 gene, which is not paused, does not
contain a CpG island overlapping its promoter, while the paused SNAI1 gene
does. Although SNAI2 does not contain a CG rich promoter sequence, it is able
to acquire pausing with increase in recruitment of Pol II. Hence, the presence of
an overlapping CpG island is not strictly required for pausing, suggesting that
mechanisms other than DNA methylation, which occurs at CpG islands, may
control pausing. Further, our finding that TSA upregulates the heat
shock HSP70 gene independent of the HSF-1 factor suggests that TSA, and
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HDAC inhibitors in general, can affect genes through bypassing their default
activation mechanisms including requirement for specific transcription factors. In
addition, using SNAI1 as an example, we show that genes do not get fully
occupied by Pol II upon activation. With the use of an artificially synthesized
bubble template for SNAI1 gene we have determined the relative level of pausing
in a population of cells. We first note that about 20% of cells contain Pol II
pausing at basal state on SNAIL gene and that Pol II pausing signal is increased
by about 2-fold upon activation with TSA. It is likely that most genes, even those
that are highly paused, are not fully occupied by Pol II, indicating that initiation of
transcription, and not pausing, may be a rate limiting step in early events of
transcription of most if not all genes.
We note that upon heat shock, HSPA1B is activated through pause
release in MCF-7 cells. A large fraction of P-TEFb is bound to the 7SK snRNP
that sequesters the kinase in an inactive state, and another fraction of P-TEFb is
found in a protein complex known as the Super Elongation Complex (SEC)
(reviewed in Luo et al 2012). The multiprotein complex of SEC appears to be
particularly important for rapid induction of transcription in stem cells (Lin et al.
2011). Although the mechanisms of recruitment of p-TEFb and SEC to gene
promoters are not completely understood, the mediator subunit MED26 has been
recently shown to be involved (Takahashi et al. 2011).
Most gene promoters contain multiple motifs for binding of transcription
factors (TF). Among such promoter binding TFs, some assist in recruiting p-TEFb
to the promoter. BRD4 and cMyc are two of the transcription factors that are
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largely studied in the context of pause escape. Similarly, HSF-1 has been shown
to recruit p-TEFb in Drosophila to promote pause release on genes upon heat
shock activation. Recently, HSF-1 was also shown to regulate pause release in
mouse cells during heat shock response (Mahat et al. 2016). While the interplay
between pausing establishment and release remains to be fully understood, our
data show that Pol II pausing remains the slowest step on heat shock genes in
human cells even at conditions of high level of gene activation.
Recent work showed that Pol II pausing, not the pre-initiation complex, is
likely the main form of Pol II near promoters in metazoans (Pugh and Venters,
2016) and our recent analysis of several individual genes supports this notion
(Samarakkody et al., 2015). Promoters recruit Pol II into a paused site that gets
distributed into distinct fates of termination versus elongation. While the exact
factors, and the interplay among factors, remain to be characterized, we suggest
that termination and pause release into productive elongationcompete during
transcriptional responses. We suggest that termination does not require P-TEFb
function (Figure 2). Thus, the fate of the paused complex is not pre-determined
during transcription initiation, but rather, determined at the paused complex.
Multiple other factors are involved in pausing and pause release. Some of these
factors are direct and some are indirect in terms of their effects on Pol II pausing.
For example, Paf1 may or may not be acting directly. It is clear, however, that Pol
II pausing emerges as a complex platform for regulatory inputs that enables
transcriptional signals through multiple mechanisms that remain to be
investigated.
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Cells orchestrate transcriptional responses by rapidly and precisely
coordinating expression of thousands of genes in a cell type specific manner.
Unlike single-celled organisms, metazoans are not driven directly by the
environment, but must follow a predetermined epigenetic program in different
environmental conditions. Metazoan cells are specialized and must undergo
responses not only respond to the signal, but also must stay within their
epigenetically specified programs. Evolutionary advantages have given
metazoans numerous means of retaining their epigenetic identity in the presence
of stress conditions, which is essential in survival of the organism. Because only
a small number of genes respond directly to the stimulus, additional mechanisms
must be involved in global transcriptional responses. How transcriptional
machinery is “primed” for transcriptional responses remains largely unclear. The
phenomenon of transcriptional pausing is a key regulatory mechanism that has
received much attention due to its prevalence in early response genes and its
association with important regulatory process such as cell differentiation,
development, and responses to stimuli. Although the duration of the paused
complex is known to change during responses to stimuli, how Pol II pausing
changes during transcriptional responses remains to be investigated in the
future. It is not clear whether activation of genes must require release of paused
Pol II, or if transcriptional events lead to a decrease in pausing duration. Here we
demonstrate that not only levels of Pol II pausing, but pause duration are
measures of the state of a gene. The availability of factors that regulate Pol II
pausing in promoter proximal regions may play a determining role in how genes
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would respond to stimuli. For instance, cMyc that plays a role in promoter
proximal regions has been shown to be overexpressed in cancer cells. Perhaps
the dysregulation of genes during disease conditions may occur at the levels of
transcription at the paused site.
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APPENDIX A
ABBREVIATIONS
7-mG cap
ATP
CBC
CBP
CDK
ChIP
ChIP-seq
CPSF
CTD
DNA
DRB
DSIF
E2
EMT
FACT
FP
GRO
GRO-seq
GTF
GTP
HIV
HSE
HSF
HSP70
HSR
IL-8

7-methylguanosine cap
Adenosine triphosphate
Cap Binding Complex
Cap Binding Protein
Cyclin-dependent Kinase
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation sequencing
cleavage and polyadenylation specificity factor
Carboxyl-Terminal Domain
Deoxyribonucleic Acid
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole
(DRB) Sensitivity-Inducing Factor
17β-Estradiol
Epethelial to Mesenchymal Transition
Facilitates Chromatin Transcription
Flavapiridol
Global Run-on
Global Run-on-sequencing
General Transcription Factors
Guanosine triphosphate
Human Influenza Virus
Heat Shock Element
Heat Shock Facor
Heat Shock Protein 70
Heat Shock Response
Interleukin-8
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MAPK
mG cap
min
mRNA
NELF
NF-κB
nt
PAF
PCF11
PCR
PI3K
PIC
Pol II
Pro-seq
p-TEFb
RNA
RT
RT-PCR
SAM
scRNA
scRNA-seq
snRNP
TES
TF
TNF-α
TRP
TSA
TSS
TTF
XRN-2

Mitogen-Activated Protein Kinase
methylguanosine
minutes
messenger RNA
Negative Elongation Factor
Neclear Factor Kappa Beta
nucleotide
Polymerase II Asssociated Factor
Cleavage and Polyadenylation Factor subunit
Polymerase Chain Reaction
Phosphoinositide 3-kinase
Pre-initiation Complex
RNA Polymerase II
Precision nuclear run-on sequencing
Positive Transcription Elongation Factor
Ribonucleic Acid
Reverse Transcription
Reverse Transcription- Polymerase Chain Reaction
S-adenosylmethionine
Short capped RNA
Short capped RNA sequencing
small nuclear ribonucleic proteins
Transcription End Site
Transcription Factor
Tumor Necrosis Factor alpha
Triptolide
Trichostatin A
Transcription Start Site
Transcription termination Factor
5'-3' exoribonuclease 2
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APPENDIX B
LIST OF PRIMERS
hCDH1+272A
hCDH1+272B
hCDH1+272C
hSnail+210A
hSnail+210B
hSnail+210C
hSlug+225A
hSlug+225B
hSlug+225C
mSnail+259A
mSnail+259B
mSnail+259C

tttcttggaagaagggaag
ttcttggaagaagggaagc
agaagggaagcggtgacgac
caatggtccacaaaacatc
acatcctgtgactcgatcct
tgtctcccccaaacctcctg
tttgcaaagctctagatacg
tgtccagttcgctgtagttt
ggctttttggaggcgttgaa
agctccagatccacctgt
gctccagatccacctgtc
gcagagcccgattctcacct
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